Michael F. MacLean - 16 Jun 2021 Form 3 Insider Report for Verve Therapeutics, Inc. (VERV)

Role: Director
Signature: /s/ Andrew Ashe, Attorney-in-Fact
Issuer symbol: VERV
Transactions as of: 16 Jun 2021
Transactions value $: $0
Form type: 3
Filing time: 16 Jun 2021, 19:40:39
Next filing: 21 Jun 2021
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit Index: 24.1 Power of Attorney